Abstract:Metastatic melanoma is the most lethal form of skin cancer strongly associated with the inflammatory process by secreting high levels of proinflammatory cytokines and producing reactive oxygen and nitrogen species. Chronic inflammation is considered as a major factor to promote the tumor microenvironment in advantage of resistance to radiation, chemotherapy, and biotherapy for metastatic melanoma. CDDO-Me, a novel synthetic triterpenoid, has been shown to exert potent anti-inflammatory and antitumor activity by decreasing oxidative stress and the production of pro-inflammatory molecules, such as Nrf2 and iNOS, in several tumor models. CDDO-Me is presently under evaluation in clinical studies for chronic kidney disease and pancreatic cancer. Here, we used CDDO-Me as a primary agent to inhibit metastatic melanoma growth. In order to improve CDDO-Me response in melanoma cells, we utilized a large-scale synthetic lethal RNAi screen with 24,000 siRNAs targeting ∼6,000 human druggable genes to identify targets that when silenced would sensitize melanoma cells to CDDO-Me. Results from the screens identified twenty of siRNA pools that significantly potentiated the growth inhibitory effects of CDDO-Me in A375 cells. We selected five unique genes, GNPAT, SUMO1, SPUNT2, FLI1, and SSX1, which have not been addressed as drug targets in melanoma before, for target validation and functional analysis in four metastatic melanoma and control cell lines. Specific siRNA against each of these five genes could substantially sensitize four tested melanoma cells to CDDO-me by increasing the growth inhibition and induction of apoptosis, while treatment with nontarget siRNA resulted in no change compared to the treatment with CDDO-Me only. Further studies of downstream signaling revealed that these five genes involved in regulating melanoma cell proliferation and cell death. We identified for the first time that the levels of phosphorylated Erk1/2, Akt, GSK-2, and PRAS40, were dramatically decreased by individual siRNA against GNPAT, SUMO1, SPUNT2, FLI1, and SSX1. Our findings indicate that GNPAT, SUMO1, SPUNT2, FLI1, and SSX1 may play critical roles in synergy with inflammation pathways in modulating melanoma cell survival, which could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma. Supported by MDACC SPORE in Melanoma P50CA093459. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1833. doi:1538-7445.AM2012-1833

Preliminary Study on the Mechanism of C-myc Antisense Oligodexynucleotide Against Malignant Melanoma Cells

Antisense C - Myc Sensitizes Osteosarcoma Cells to Cisplatin- Induced Apoptosis

Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.

[Adenovirus Mediated Antisense C-Myc Gene on the Chemotherapy Sensitivity of Osteosarcoma Cells to Cisplatin].

Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.

Antisense Oligonucleotide Inhibits the Growth of Human Melanoma Cells and Influences Its Cycle

Inhibitory effects of antisense oligodexynucleotide on the expression of survivin mRNA and protein in human malignant melanoma cell line A375

[Effect of survivin antisense oligodeoxynucleotide on proliferation and apoptosis of human malignant melanoma cells]

Antisense Oligodeoxynucleotide Inhibits the Expression of Cyclin D 1 and Its Influence on Growth of Melanoma Cells

[Effects of Bcl-2 Antisense Oligodeoxynucleotide on Proliferation and Apoptosis of Human Melanoma A375 Cell Line].

Effect of Survivin Antiseme Oligonucleotide on Biological Behaviors of Human Malignant Melanoma A375 Cells

The inhibitory effect of c-myc antisense oligodeoxynucleotide on the growth of renal carcinoma cell and effect on cell cycle

Experimental studies of optimized transfection condition on human malignant melanoma cell by survivin antisense oligonucleotide

Synthesis and Evaluation of the Anticancer Activity of Albiziabioside A and Its Analogues As Apoptosis Inducers Against Human Melanoma Cells.

Biological effects of liposome-mediated c-myc antisense oligodeoxynucleotide on human hepatoma cells

Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy

The effect of antisense c-myc by liposomes on the growth of human hepatoma in nude mice

Abstract 1833: A large-scale synthetic lethal RNAi screening identifies unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma

[Inducing Apoptosis of HeLa Cell Lines by Transfection of C-Myc Antisense Oligonucleotides].

Anti-neoplasm and immuno-modification effect of novel CpG oligodeoxynucleotides in mice

Nitidine Chloride Inhibits Proliferation and Induces Mitochondrial-Mediated Apoptosis of Human Melanoma A375 and A2058 Cells In Vitro